Zidovudine Genotypic Resistance in HIV-1–Infected Newborns in the French Perinatal Cohort
- 1 June 2001
- journal article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 27 (2) , 99-104
- https://doi.org/10.1097/00042560-200106010-00001
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Antiretroviral Drug Resistance Testing in Adults With HIV InfectionJAMA, 1998
- Acceptability and impact of zidovudine for prevention of mother-to-child human immunodeficiency virus–1 transmission in FranceThe Journal of Pediatrics, 1997
- Lamivudine-resistant human immunodeficiency virus type 1 variants (184V) require multiple amino acid changes to become co-resistant to zidovudine in vivo.The Journal of Infectious Diseases, 1997
- Maternal Factors Associated with Perinatal HIV-1 TransmissionJAIDS Journal of Acquired Immune Deficiency Syndromes, 1995
- Mother to child transmission of zidovudine-resistant HIV-1The Lancet, 1994
- Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine TreatmentNew England Journal of Medicine, 1994
- Primary Infection with Zidovudine-Resistant HIVNew England Journal of Medicine, 1993
- Fifth mutation in human immunodeficiency virus type 1 reverse transcriptase contributes to the development of high-level resistance to zidovudine.Proceedings of the National Academy of Sciences, 1992
- Ordered Appearance of Zidovudine Resistance Mutations during Treatment of 18 Human Immunodeficiency Virus-Positive SubjectsThe Journal of Infectious Diseases, 1992
- Multiple Mutations in HIV-1 Reverse Transcriptase Confer High-Level Resistance to Zidovudine (AZT)Science, 1989